What question did this study set out to answer?

To assess the effectiveness of a multimodal protocol on glycaemic, anthropometric, and lipid outcomes in patients with complex type 2 diabetes mellitus.

June 1, 2026Open Access

Glycaemic, Anthropometric, and Lipid Outcomes of CDC Dm Package Intervention in 10 Complex T2dm Patients at Navi Mumbai–panvel: A Pilot Retrospective Analysis

Puntos clave

To assess the effectiveness of a multimodal protocol on glycaemic, anthropometric, and lipid outcomes in patients with complex type 2 diabetes mellitus.
Retrospective observational study of 10 T2DM patients enrolled in the DM Package.
Utilized paired Student's t-test for within-group pre–post comparisons.
Descriptive statistics were performed to analyze changes in RBS, weight, BMI, and lipid levels.
Mean RBS decreased from 229.80 to 142.40 mg/dL (Δ −87.40 mg/dL, −38.0%, p<0.001).
Weight reduced by −4.78 kg (−6.4%, p=0.002) and BMI decreased by −2.02 kg/m² (−6.9%, p=0.003).
All patients achieved 100% partial medication reduction with meaningful lipid changes reported.

Resumen

Background: Navi Mumbai-Panvel's DM Package cohort (n=10), while small, includes patients with complex comorbidities (DM+CAD, DM+IHD, multi-system disease) and 100% medication reduction documentation. This pilot analysis evaluates protocol efficacy in a complex, high-cardiovascular-risk diabetic population. Objective: To evaluate the effect of the Madhavbaug CDC Panchakarma-based multimodal protocol on glycaemic, anthropometric, cardiometabolic, and medication parameters exclusively in DM Package patients (n=10) at the Navi Mumbai (Panvel) Central RIC clinic. Methods: Retrospective observational study. 10 T2DM patients enrolled in the DM Package at Navi Mumbai (Panvel) Central RIC. Only DM Package care plans (CDC-SP Base/1/2/3, CDC-KP Base/1/2/3, DM-HTN 1/2/3) included. Paired Student's t-test (two-tailed) for within-group pre–post comparisons (p<0.05 significant). Descriptive statistics as mean ± SD. Results: RBS reduced significantly from 229.80±81.28 to 142.40±44.58 mg/dL (Δ −87.40 mg/dL, −38.0%, p<0.001, n=10). Weight fell by −4.78 kg (−6.4%, p=0.002). BMI −2.02 kg/m² (−6.9%, p=0.003). Abdominal girth −4.90 cm (−5.0%, p=0.003). DBP −5.40 mmHg (−6.1%, p=0.033). Total cholesterol showed a clinically meaningful reduction of −35.40 mg/dL (−18.1%, p=0.069, n=8). Triglycerides reduced by −27.05 mg/dL (−10.4%, p=0.040, n=8). All 10 patients achieved partial medication reduction (100% partial medication reduction rate). Conclusion: Despite its small sample (n=10), Navi Mumbai-Panvel's DM Package demonstrates exceptional results: RBS −38.0% (p<0.001), weight −6.4% (p=0.002), BMI −6.9% (p=0.003), abdominal girth −5.0% (p=0.003), triglycerides −10.4% (p=0.040), and DBP −6.1% (p=0.033). The 100% partial medication reduction rate and clinically meaningful lipid trends represent the strongest combined anthropometric and pharmacoeconomic outcomes in the Central RIC DM network.

Leer artículo completoexternamente

Me gusta

Guardar

Ver artículo completo